Functional and Mechanistic Explanation for the Unique Clinical Success of the Glucokinase Activator Dorzagliatin in the Treatment of Type 2 Diabetes is a research paper published in Diabetes (2025). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Diabetes Research Center, Institute for Diabetes, Obesity and Metabolism, Perelman School of Medicine, University of Pennsylvania
Grant: P30DK19525
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01DK136564
NIDDK NIH HHS
Grant: P30 DK019525
NIDDK NIH HHS
Grant: U01 DK123716
NIDDK NIH HHS
Grant: UC4 DK112232
NIDDK NIH HHS
Grant: U24 DK098085
NIDDK NIH HHS
Grant: UC4 DK112217
NIDDK NIH HHS
Grant: U01 DK123594
MeSH Terms